Hôpital Larrey, CHU de Toulouse, Service de Pneumologie

Toulouse, Midi-pyrenees 31059

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis

Studies at this site

• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early